FAP and cancer: Consequently, the smaller molecular size of FAPI-02, -04, -46 compared to FAP-2286 offers advantages for the imaging and detection of cancer that express FAPs, and therapeutic advantages are also potentially present if the tumor-to-background ratio is optimized for the decay time of the therapeutic radioisotope, thus avoiding unnecessary radiation doses to healthy tissue and organs.